Additionally, in order to validate what percentage of cells expressed Oct4 in in vivo tissue, we counted the number of Oct4‐positive cells in the aorta area of the progeria mouse after delivery of dCas9‐Oct4 activator. The gene discussed is POU5F1; the disease is progeroid syndrome.